News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
Servier on Trial Over Diabetes-Diet Pill
May 14, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
(Reuters) - French drugmaker Servier and its founder went on trial on Monday accused of misleading patients and authorities about a diabetes drug often prescribed for weight loss that officials blame for at least 500 deaths.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
MORE ON THIS TOPIC
Special edition
Deep Dive: Biopharma In Turmoil As Peter Marks Forced Out of FDA
May 9, 2025
·
2 min read
·
Annalee Armstrong
Manufacturing
Trump Orders FDA To Ease US Plant Expansion; Drops Hammer on Foreign Inspections
May 6, 2025
·
3 min read
·
Annalee Armstrong
Legal
States Sue RFK Jr., Makary, Seeking To Block HHS Cuts
May 6, 2025
·
2 min read
·
Tristan Manalac
Editorial
Biomedical Innovation in Jeopardy as Kennedy Distorts, Denies Scientific Truths
May 2, 2025
·
6 min read
·
Heather McKenzie
